CWM
GCVRZ

Concert Wealth Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Concert Wealth Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15
Closed – – 1038
2016
Q3 		$0 Buy
+15
New +$4 ﹤0.01% 1061

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Concert Wealth Management's GCVRZ Position: Q4 2016 in Review

Concert Wealth Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2016, closing a stake of 15 shares.

Concert Wealth Management first reported a position in GCVRZ in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

  • Concert Wealth Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
  • Concert Wealth Management sold 15 Sanofi Contingent Value Rights shares in Q4 2016.
  • Concert Wealth Management first reported a position in Sanofi Contingent Value Rights in Q3 2016 and held it in 1 quarter.
  • Concert Wealth Management's Sanofi Contingent Value Rights position peaked at $0 in Q3 2016.
  • 120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on Concert Wealth Management's 13F filing for Q4 2016, filed 10 Feb 2017.